ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO980

Defective ATP Synthase Mediates Renal Fibrosis and Tubular Epithelial-Mesenchymal Transition

Session Information

Category: Pathology and Lab Medicine

  • 1601 Pathology and Lab Medicine: Basic

Author

  • Sung, Junne-Ming, National Cheng-Kung University Hoispital, Tainan, Taiwan
Background

Reduced mitochondrial function is a feature of chronic kidney disease (CKD). However, there is limited understanding of various aspect of mitochondrial biology in the renal injury.

Methods

This study aims to explore the role of mitochondrion dysfunction on TGFβ1–induced tubular cell epithelio-mesenchyamal transition (EMT) in vitro and renal fibrosis in vivo and clinical renal biopsy samples from patients with various stage of CKD.

Results

We observed TGFβ1-induced EMT in cultured renal tubular HK2 cells, and found that TGFβ1-treated cells have a decrease of oxygen consumption and an increase in use of non-oxidative phosphorylation glycolysis pathway as their energy source (by seahorse assay) while undergoing EMT, which was accompanied by increased mitochondrial membrane potential (MMP) and lower complex V activity (The activities of complex 1-IV were normal). Adding a mitochondrial complex V inhibitors (oligomycin) may induce EMT and further enhances TGF-β1-induced EMT. Blue native (BN)-PAGE studies showed a defective assembly of complex V (ATP synthase) in the mitochondria of EMT cells, which was possibly attributed by attenuation of its assembly factor ATPAF1. In HK2 cells, ATPAF1 knockdown caused EMT, and restoration of ATPAF1 protects renal tubule cells from TGFβ-induced mitochondrial dysfunction and EMT. Consistently, the animal model of tubulointerstitial fibrosis caused by unilateral ureteral obstruction (UUO) demonstrated attenuations in ATPAF1 level and complex V formation, accompanied by increased MMP. Overexpression of Atpaf1 in vivo attenuated mitochondrial dysfunction of tubular cells and interstitial fibrosis in UUO animal model. Thus, restoration of ATPAF1 in the kidney is protective against injury during the progression of renal fibrosis. In clinical renal biopsy samples , we performed immunostaining for ATPAF1, MMP and α-smooth muscle actin(α-SMA, a marker of fibrosis) and found that the severity of interstitial fibrosis (α-SMA staining intensity) negatively correlated with tubular ATPAF1 and positively with MMP. In addition, tubular ATPAF1 intensity also negatively correlated with MMP staining.

Conclusion

Our study underscores ATPAF1 is an important factor in maintaining mitochondrial energy capacity in tubule cells, and is vulnerability to injury and mediates the development of renal fibrosis.